Biostar Pharmaceuticals Profit Margin

As of the most recent data (September 2017), BSPM shows a profit margin of 98.6%. That compares with -842.53% in the prior-year period — up 111.7% year over year. That is above the sector sector average of 21.34%. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, BSPM's profit margin is now 98.6% (was -842.53%) — a 111.7% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Biostar Pharmaceuticals is outperforming or lagging.

The its sector sector average profit margin is about 21.34%. Biostar Pharmaceuticals is at 98.6%, which is higher that average. That is roughly 362.0% above the sector mean. Use the comparison chart on this page to see how BSPM stacks up against individual peers as well.

That compares with -842.53% in the prior-year period — up 111.7% year over year. Improvement over multiple periods is generally more meaningful than a single strong quarter. Compare Biostar Pharmaceuticals with peers to see if the move is company-specific or sector-wide.

Besides this profit margin page, Stockcircle has Biostar Pharmaceuticals's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect profit margin (currently 98.6%) with ownership activity and broader fundamentals.